StonvexLoading…
StonvexStonvexStonvexCore line items from LEG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.06B | $4.38B | $4.73B | $5.15B |
Operating Income | $289.70M | $-509.20M | $-173.40M | $403.60M |
Net Income | $235.40M | $-511.50M | $-136.80M | $309.80M |
EPS (Diluted) | $1.69 | $-3.73 | $-1.00 | $2.27 |
Total Assets | $3.54B | $3.66B | $4.63B | $5.19B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $587.40M | $350.20M | $365.50M | $316.50M |
Free Cash Flow OCF − CapEx | $281.00M | $224.10M | $383.40M | $341.10M |
Shares Outstanding | 139.70M | 137.30M | 136.30M | 136.50M |